Bone density and microarchitecture in Graves' disease: evaluating treatment and vitamin D supplementation

Affiliations

¹ Department of Bioinformatics, School of Basic Medical Sciences, Chongqing Medical University, No. 1 Yixueyuan Rd, Box 197, Chongqing, 400016, China. 2021220107@stu.cqmu.edu.cn.
² Department of Bioinformatics, School of Basic Medical Sciences, Chongqing Medical University, No. 1 Yixueyuan Rd, Box 197, Chongqing, 400016, China.
³ Department of Bioinformatics, School of Basic Medical Sciences, Chongqing Medical University, No. 1 Yixueyuan Rd, Box 197, Chongqing, 400016, China. liuth@cqmu.edu.cn.

Wei-Zhen Tang et al. Osteoporos Int. 2025 Feb.

. 2025 Feb;36(2):345-346.

doi: 10.1007/s00198-024-07290-3. Epub 2024 Nov 1.

¹ Department of Bioinformatics, School of Basic Medical Sciences, Chongqing Medical University, No. 1 Yixueyuan Rd, Box 197, Chongqing, 400016, China. 2021220107@stu.cqmu.edu.cn.
² Department of Bioinformatics, School of Basic Medical Sciences, Chongqing Medical University, No. 1 Yixueyuan Rd, Box 197, Chongqing, 400016, China.
³ Department of Bioinformatics, School of Basic Medical Sciences, Chongqing Medical University, No. 1 Yixueyuan Rd, Box 197, Chongqing, 400016, China. liuth@cqmu.edu.cn.

No abstract available

Conflict of interest statement

Declarations. Conflicts of interest: None.

1. Grove-Laugesen D et al (2024) Changes in bone density and microarchitecture following treatment of Graves’ disease and the effects of vitamin D supplementation. A randomized clinical trial. Osteoporos Int. https://doi.org/10.1007/s00198-024-07241-y
1. Bartalena L et al (2016) The 2016 European Thyroid Association/European Group on Graves’ orbitopathy guidelines for the management of Graves’ orbitopathy. Eur Thyroid J 5:9–26 - DOI - PubMed - PMC
1. O’brien CA et al (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835–1841 - DOI - PubMed
1. Rymuza J et al (2022) Therapy with intravenous methylprednisolone pulses is associated with loss of bone microarchitecture in trabecular bone score -assessment among patients with moderate-to-severe Graves’ orbitopathy: a pilot study. Front Endocrinol (Lausanne) 13:893600 - DOI - PubMed
1. Rymuza J et al (2019) Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density. Endocrine 64:308–315 - DOI - PubMed